These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 18626164)
1. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement. Chen C; Chen LQ; Yang GL; Li Y J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164 [TBL] [Abstract][Full Text] [Related]
2. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related]
3. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases. Yang XQ; Chen C; Peng CW; Liu SP; Li Y Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105 [TBL] [Abstract][Full Text] [Related]
4. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement. Yang XQ; Yan L; Chen C; Hou JX; Li Y Hepatogastroenterology; 2009; 56(94-95):1388-94. PubMed ID: 19950797 [TBL] [Abstract][Full Text] [Related]
5. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
6. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053 [TBL] [Abstract][Full Text] [Related]
7. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Yang XQ; Chen C; Wang FB; Peng CW; Li Y Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276 [TBL] [Abstract][Full Text] [Related]
8. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer. Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma. Zhang SY; Lin M; Zhang HB Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
11. [Detection and clinical study of serum tumor markers in patients with colorectal cancer]. Zhao XW; Jiang B; Han CZ; Jing JX Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321 [TBL] [Abstract][Full Text] [Related]
12. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876 [TBL] [Abstract][Full Text] [Related]
13. Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers. Singh S; Kumar R; Kumar U; Kumari R Asian Pac J Cancer Prev; 2020 Nov; 21(11):3133-3136. PubMed ID: 33247667 [TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer. Wang YR; Yan JX; Wang LN J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941 [TBL] [Abstract][Full Text] [Related]
15. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
16. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885 [TBL] [Abstract][Full Text] [Related]
17. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer. Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311 [TBL] [Abstract][Full Text] [Related]
18. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer. Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510 [TBL] [Abstract][Full Text] [Related]
19. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125 [TBL] [Abstract][Full Text] [Related]
20. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]